What are you searching for?

01.04.2020 | Tracker

Top 50 Pharma Tracker: HCPs mentioning Pharma in Relation to COVID-19

By Mary Kangley

Top 50 Pharma Tracker: HCPs mentioning Pharma in Relation to COVID-19

March’s Top 50 Pharmaceutical Companies mentioned by HCPs on Twitter

MarFebCompanyTotal MentionsAccount mentionsAccount retweetsNumber of Twitter
accounts mentioned
13Gilead22511124261
28Roche17118784810
318Abbott107510748853
421Biogen7442903
51Johnson & Johnson*58930613420
64Novartis4381597810
72Sanofi3651707713
827Teva360138788
926Regenero326172171
109Bayer29379487
115GSK257127627
126Pfizer19490409
1320Mylan1371311
1410Lilly10447212
1517AbbVie854937
167Merck & co765372
1715Takeda662146
1811AstraZeneca493065
1939Grifols48000
2012Novo Nordisk4232115
2123Fresenius27652
2213Boehringer1918114
2341Sun18302
2432CSL15101
2542Menarini151292
2616Amgen141575
2736Daiichi-Sankyo11833
2814BMS8932
2935Bausch8000
3025UCB6514
3131Ipsen5572
3222Allergan4201
3324Merck KGaA4212
3443Celgene4101
3529Vertex3301
3630Astellas3402
3719Eisai3000
3828Servier2030
5038Otsuka0141
5045Shire**0000
5037Ferring0000
5047Chugai0000
5040Alexion0000
5033Stada arzneimittel0301
5034Mallinckrodt0000
5046Sumitomo dainippon0000
5050Jiangsu hengrui0000
5044Endo0000
5050Mitsubishi tanabe pharma0000
5050Sino0000

In March 2020, CREATION Pinpoint® identified 8,087 healthcare professional (HCP) authored tweets about COVID-19 from 5,110 individual HCPs mentioning a top-50 pharmaceutical company (according to revenue). This is an increase in total HCP mentions of pharmaceutical companies compared to previous months, which included all mentions of a top-50 pharma company on Twitter.

Over half of all COVID-19 specific HCP mentions in top 50 pharmaceutical companies in March were in relation to diagnosis and testing of COVID-19.

The five pharmaceutical companies that were mentioned the most by HCPs relating to COVID-19 on Twitter in March 2020 were Gilead, Roche, Abbott, Biogen and Johnson and Johnson (J&J).

Mentions of Gilead had nearly quadrupled since February as HCPs discussed their potential COVID-19 treatment, remdesivir, many asking for compassionate use.

Both Roche and Abbott mentions were driven by FDA approvals of their COVID-19 tests, with volume of posts spiking at these announcements.

The conversation online has increased since the beginning of 2020, due to the COVID-19 pandemic. CREATION.co continues to track this online discussion and recently ran two webinars sharing advice for health communicators in government, NGOs and pharmaceutical companies during the pandemic:


READ LAST MONTH’S TOP 50 PHARMA TRACKER:

Top 50 Pharma Tracker: New year begins with failed trials and successful podcast launch


Methodology notes:

  • In March 2020, CREATION Pinpoint® identified 8,087 healthcare professional (HCP) authored tweets about COVID-19 from 5,110 individual HCPs mentioning a top-50 pharmaceutical company (according to revenue).
  • Data for this research was analysed from the online Twitter conversations of HCPs in relation to COVID-19 in all languages mentioning a Top 50 pharmaceutical company between March 1st and March 31st 2020.
  • Unless otherwise specified, mentions of a company are not limited to its Twitter account(s).
  • In some cases, a tweet may mention more than one company account (eg. @abbottnews and @abbottglobal) – this only counts as one Company Mention but two Account Mentions.
  • The Number of Twitter Accounts Mentioned only include those accounts mentioned by HCPs.
  • * Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Janssen.
  • ** Whilst included in the Top 50 Pharma list according to revenue from 2019, Shire has since been acquired by Takeda and no longer holds a Twitter account.

View all articles >

Meet the Author

Mary Kangley

As a Health Insights Consultant Mary is passionate about telling stories with data from online healthcare conversations. Her work is guided by a background in human and cyber-psychology providing a curiosity to understand what HCPs think.

As a keen music fan, Mary’s greatest pride is her Spotify playlists that are continually growing as she makes new discoveries.

Suggested next


How HCPs' changing behaviour is transforming pharmaceutical strategy

29.11.2018 | Article

How HCPs’ changing behaviour is transforming pharmaceutical strategy

How HCPs' changing behaviour is transforming pharmaceutical strategy

By Suzanna Gamwell

Top 50 Pharma Tracker: HCPs discuss Gilead, Eisai and Merck & Co’s trial results

06.03.2020 | Article

Top 50 Pharma Tracker: HCPs discuss Gilead, Eisai and Merck & Co’s trial results

Top 50 Pharma Tracker: HCPs discuss Gilead, Eisai and Merck & Co’s trial results

By Mary Kangley

View all articles >